Aspira Pathlab & Diagnostics informs about disclosure

04 Jul 2022 Evaluate
Aspira Pathlab & Diagnostics has informed that it attached disclosure in Form - C pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. This intimation is in compliance with Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Aspira Pathlab&Diagn Share Price

68.35 1.60 (2.40%)
05-Dec-2025 15:40 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7193.05
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1918.30
Aster DM Healthcare 635.10
Global Health 1171.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×